Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

See also
Status	Clinical Trial	Phase
Completed	`NCT00678392` - Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer	Phase 3
Not yet recruiting	`NCT03129724` - Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib	N/A
Terminated	`NCT01413607` - The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy	Phase 4
Terminated	`NCT00091611` - Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer	Phase 1
Terminated	`NCT02439008` - Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response	N/A
Completed	`NCT01688999` - Cabozantinib for Advanced Urothelial Cancer	Phase 2
Recruiting	`NCT05184504` - Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American
Completed	`NCT04933604` - LPN in Patients With High-complex Renal Tumors
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT05119335` - A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma	Phase 1/Phase 2
Terminated	`NCT02543645` - A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer	Phase 1
Terminated	`NCT01712685` - Imaging Studies of Kidney Cancer Using 18F-VM4-037	Phase 2
Terminated	`NCT00816686` - A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer	Phase 1
Completed	`NCT00537056` - Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI	N/A
Completed	`NCT00076011` - Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma	Phase 2
Completed	`NCT00226980` - A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma	Phase 2
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Recruiting	`NCT03062410` - Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma	N/A
Completed	`NCT02924922` - Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy	N/A

NCT number	NCT00920816
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	August 25, 2009
Completion date	April 29, 2021

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms